[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-360199-105":59,"doc-detail-360199-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","bioinformatics-analysis-of-pbld-as-a-potential-biomarker-in-pan-cancer-and-colon-adenocarcinoma","Bioinformatics analysis of PBLD as a potential biomarker in pan-cancer and colon adenocarcinoma","","Bioinformatics analysis evaluates phenazine biosynthesis-like protein domain-containing protein (PBLD) across pan-cancer and colon adenocarcinoma (COAD) to determine biomarker potential for diagnosis and treatment. The study integrates multiple public expression and survival resources, genomic alteration tools, and tumor microenvironment and drug-sensitivity databases, then correlates PBLD with TMB, MSI, immune infiltration, and therapeutic response. Results show PBLD is downregulated in 14 cancers, associated with poor prognosis and metabolism–immune pathway involvement.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bioinformatics-analysis-of-pbld-as-a-potential-biomarker-in-pan-cancer-and-colon-adenocarcinoma/360199/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bioinformatics-analysis-of-pbld-as-a-potential-biomarker-in-pan-cancer-and-colon-adenocarcinoma/360199.png","ImageObject",300,407,{"name":92,"@type":93},"Terk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-14","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main purpose of the study on PBLD in pan-cancer and COAD?","Question",{"text":112,"@type":113},"To determine whether PBLD can serve as a potential biomarker and to explore its role in cancer diagnosis and treatment, with emphasis on colon adenocarcinoma (COAD).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was PBLD investigated in the study?",{"text":117,"@type":113},"By integrating public bioinformatics databases for expression patterns, survival value, genomic alterations, tumor microenvironment associations, and drug sensitivity, followed by correlation, functional enrichment, and network analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"What key findings connect PBLD with prognosis and tumor biology?",{"text":121,"@type":113},"PBLD is significantly downregulated in 14 cancers and is associated with poor prognosis, with expression correlating to TMB/MSI, immune infiltration, and drug sensitivity, and enrichment pointing to amino-acid and lipid metabolism pathways.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},360199,1790939084,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Original Article  \nBioinformatics analysis of PBLD as a potential biomarker in pan-cancer and colon adenocarcinoma  \nJiayue Chen\\# , Xiaoqiong Chen\\# , Yuanhao Wei\\# , Jinyuan Ou, Lanxi Yue, Xuanle Li, Bing Huang, Fachao Zhi, Xinmei Zhao^  \nGuangdong Provincial Key Laboratory of Gastroenterology, Institute of Gastroenterology of Guangdong Province, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, China  \nContributions: (I) Conception and design: X Zhao, F Zhi; (II) Administrative support: X Zhao; (III) Provision of study materials or patients: X Zhao, B Huang; (IV) Collection and assembly of data: J Chen, J Ou, L Yue, X Li; (V) Data analysis and interpretation: J Chen, X Chen, Y Wei; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \n\\#These authors contributed equally to this work.  \nCorrespondence to: Xinmei Zhao, MD; Fachao Zhi, MD. Guangdong Provincial Key Laboratory of Gastroenterology, Institute of Gastroenterology of Guangdong Province, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, No. 1838 Guangzhou Avenue North, Guangzhou 510515, [China. Email: xmzhao914@163.com](China. Email: xmzhao914@163.com); [zhifc41532@163.com](zhifc41532@163.com).  \nBackground: Malignancies are the leading cause of global mortality, necessitating new biomarkers and therapeutic targets. Phenazine biosynthesis-like protein domain-containing protein (PBLD) has demonstrated tumor-suppressive activity in gastric and liver cancers, although its pan-cancer function remains elusive. In this study, we performed bioinformatics analysis of PBLD in pan-cancer and colon adenocarcinoma (COAD)  \nto explore its potential role, aiming to provide new insights for cancer diagnosis and treatment.  \nMethods: This study systematically investigated the expression of PBLD patterns, its prognostic value, genomic alterations, associations with the tumor microenvironment (TME), and drug sensitivity in cancers, with a focus on COAD. This study performed integrated database analyses using Human Protein Atlas (HPA), Genotype Tissue Expression (GTEx), and Tumor Immune Estimation Resource version 2.0 (TIMER2.0) for normal/tumor expression; Gene Expression Profiling Interactive Analysis (GEPIA2) and Gene Set Cancer Analysis (GSCA) for survival and pathological staging; and cBioPortal for genetic alterations. Correlation analyses were performed to assess associations with tumor mutational burden (TMB)/microsatellite instability (MSI), immune infiltration (TIMER2.0, Spearman), and drug responsiveness [Genomics of Drug Sensitivity in Cancer (GDSC)/Cancer Therapeutics Response Portal (CTRP) through GSCA] . Functional enrichment [Gene Ontology (GO)/Kyoto Encyclopedia of Genes and Genomes (KEGG)/Gene Set  \nEnrichment Analysis (GSEA)], and protein-network analysis (STRING) were also conducted.  \nResults: PBLD was significantly downregulated in 14 cancers, notably in bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), cholangiocarcinoma (CHOL), COAD, esophageal carcinoma (ESCA), kidney chromophobe (KICH), kidney renal clear cell carcinoma (KIRC), kidney renal papillary cell carcinoma (KIRP), liver hepatocellular carcinoma (LIHC), lung squamous cell carcinoma (LUSC), and rectum adenocarcinoma (READ), and was associated with a poor prognosis. Its expression was correlated with TMB/MSI, immune cell infiltration, and drug sensitivity. Enrichment analyses revealed the important role of PBLD in the amino acid and lipid metabolism pathways. COAD-specific analyses further identified associations among suppressed PBLD expression, metabolic dysregulation, immune activation, and epigenetic  \nsilencing.  \nConclusions: These findings establish PBLD as a pan-cancer prognostic biomarker with mechanistic links  \nto metabolism and immune modulation, supporting its potential role for precision cancer management.  \n^ ORCID: 0000-0003-3940-788X.  \n© AME Publishing Company. Tr","cbCaimw8G2RMzKpJ","https://ap.wps.com/l/cbCaimw8G2RMzKpJ","pdf",8662542,18,"English","# Introduction\n# Methods\n# Results\n# Conclusions\n# Key findings","[{\"question\":\"What was the main purpose of the study on PBLD in pan-cancer and COAD?\",\"answer\":\"To determine whether PBLD can serve as a potential biomarker and to explore its role in cancer diagnosis and treatment, with emphasis on colon adenocarcinoma (COAD).\"},{\"question\":\"How was PBLD investigated in the study?\",\"answer\":\"By integrating public bioinformatics databases for expression patterns, survival value, genomic alterations, tumor microenvironment associations, and drug sensitivity, followed by correlation, functional enrichment, and network analyses.\"},{\"question\":\"What key findings connect PBLD with prognosis and tumor biology?\",\"answer\":\"PBLD is significantly downregulated in 14 cancers and is associated with poor prognosis, with expression correlating to TMB/MSI, immune infiltration, and drug sensitivity, and enrichment pointing to amino-acid and lipid metabolism pathways.\"}]","Bioinformatics analysis of PBLD as a potential biomarker in pan-cancer and colon adenocarcinoma | PDF",1790139045,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba0332696a50f8e67e52fa072fb160f9.webp",983,1287,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7e776cf70894b635133b4c800fb8e61.webp",982,1286,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd37324159b911cec493de9f79121268.webp",981,1284,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9a911027d78e48e75c6999618137888.webp",980,1283]